Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Methylene Blue in Acquired Methemoglobinemia: Prospective Observational Registry (metHb)

NCT03542760 is registered in ClinicalTrials.gov with Hospital Quality Foundation as lead sponsor.

NCT NCT03542760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03542760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Methylene Blue in Acquired Methemoglobinemia: Prospective Observational Registry (metHb)
Lead sponsor
Hospital Quality Foundation
Phase
Observational
Overall status
Completed
Start date
May 31, 2018
Completion date
August 31, 2021
Enrollment
24 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

methemoglobinemia, methemoglobinemia, acquired